Bioventus Inc. (BVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 60M 120M 180M Q4 '21: 108.9M Q4 '21: 130.4M Q2 '22: 117.3M Q3 '22: 140.3M Q4 '22: 128.7M Q4 '22: 125.8M Q2 '23: 119.1M Q3 '23: 137.1M Q3 '23: 120.8M Q4 '23: 135.4M Q1 '24: 129.5M Q2 '24: 151.2M Q3 '24: 139M Q4 '24: 153.6M Q1 '25: 123.9M Q2 '25: 147.7M Q3 '25: 138.7M Q4 '25: 157.9M Q1 '26: 132.1M Q2 '26: 153.2M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 40M 80M 120M Q4 '21: 79.1M Q4 '21: 87.8M Q2 '22: 75.7M Q3 '22: 96.7M Q4 '22: 84.5M Q4 '22: 74.2M Q2 '23: 73.9M Q3 '23: 89.1M Q3 '23: 78.8M Q4 '23: 86.3M Q1 '24: 88.4M Q2 '24: 103.6M Q3 '24: 93.6M Q4 '24: 102.7M Q1 '25: 83.1M Q2 '25: 102.1M Q3 '25: 94.2M Q4 '25: 108.8M Q1 '26: 90.8M Q2 '26: 105.7M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q4 '21: -1M Q4 '21: -3.1M Q2 '22: -21.4M Q3 '22: -3.3M Q4 '22: -126.8M Q4 '22: -15.6M Q2 '23: -92.1M Q3 '23: 6.8M Q3 '23: 2.4M Q4 '23: 1.2M Q1 '24: 4.9M Q2 '24: -31.5M Q3 '24: 3.6M Q4 '24: 7.7M Q1 '25: 4.9M Q2 '25: 18.4M Q3 '25: 11.3M Q4 '25: 19.5M Q1 '26: 8.4M Q2 '26: 19.1M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-150M -100M -50M 0 50M 100M 150M Q4 '21: -1.1M Q4 '21: -364K Q2 '22: -11.3M Q3 '22: -7.3M Q4 '22: -108.2M Q4 '22: -31.9M Q2 '23: -139.2M Q3 '23: -3.7M Q3 '23: -7.3M Q4 '23: -6.1M Q1 '24: -4.9M Q2 '24: -25.7M Q3 '24: -5.2M Q4 '24: -388K Q1 '25: -2.6M Q2 '25: 7.5M Q3 '25: 3.2M Q4 '25: 14.8M Q1 '26: 3.1M Q2 '26: 33.4M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 20M 40M 60M Q4 '21: 29.8M Q4 '21: 42.6M Q2 '22: 41.6M Q3 '22: 43.7M Q4 '22: 44.1M Q4 '22: 51.6M Q2 '23: 45.1M Q3 '23: 47.9M Q3 '23: 41.9M Q4 '23: 49.1M Q1 '24: 41.1M Q2 '24: 47.6M Q3 '24: 45.4M Q4 '24: 51M Q1 '25: 40.8M Q2 '25: 45.6M Q3 '25: 44.4M Q4 '25: 49.1M Q1 '26: 41.3M Q2 '26: 47.5M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-30M -15M 0 15M 30M 45M Q4 '21: 10.6M Q4 '21: 13.1M Q2 '22: -21M Q3 '22: 2.9M Q4 '22: -701K Q4 '22: 5.2M Q2 '23: 2.5M Q3 '23: 10.8M Q3 '23: -8.3M Q4 '23: 10.4M Q1 '24: -6M Q2 '24: 15.2M Q3 '24: 10.3M Q4 '24: 19.3M Q1 '25: -19.3M Q2 '25: 25.9M Q3 '25: 30.1M Q4 '25: 38M Q1 '26: 8.9M Q2 '26: 19.9M Q4 '21 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-30M -15M 0 15M 30M 45M Q3 '21: 16.1M Q4 '21: 8.7M Q4 '21: 4.2M Q2 '22: -24M Q3 '22: 909K Q4 '22: -2.4M Q2 '23: -1.1M Q3 '23: 9.4M Q3 '23: -10.4M Q4 '23: 10M Q1 '24: -6.3M Q2 '24: 15.1M Q3 '24: 10.3M Q4 '24: 18.7M Q1 '25: -20.2M Q2 '25: 25.3M Q3 '25: 29.6M Q4 '25: 37.4M Q1 '26: 8.4M Q2 '26: 18.9M Q4 '21 Q3 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '21: 41.8M Q3 '21: 41.8M Q4 '21: 41.8M Q2 '22: 60.5M Q3 '22: 61.5M Q4 '22: 61.7M Q2 '23: 62.1M Q3 '23: 62.6M Q3 '23: 62.8M Q1 '24: 63.4M Q2 '24: 64.1M Q3 '24: 65.3M Q1 '25: 66M Q2 '25: 68.5M Q3 '25: 68.8M Q1 '26: 70M Q2 '26: 70.8M Q3 '21 Q3 '22 Q3 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-6.00 -4.00 -2.00 0.00 2.00 4.00 6.00 Q2 '22: -0.32 Q3 '22: -0.33 Q4 '22: -2.06 Q4 '22: -2.58 Q2 '23: -4.63 Q3 '23: -4.58 Q3 '23: -2.94 Q4 '23: -2.51 Q1 '24: -0.35 Q2 '24: -0.69 Q3 '24: -0.65 Q4 '24: -0.56 Q1 '25: -0.52 Q2 '25: -0.01 Q3 '25: 0.12 Q4 '25: 0.33 Q1 '26: 0.41 Q2 '26: 0.77 Q4 '22 Q3 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.